Details for New Drug Application (NDA): 205873
✉ Email this page to a colleague
The generic ingredient in CISATRACURIUM BESYLATE is cisatracurium besylate. There are nine drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the cisatracurium besylate profile page.
Summary for 205873
Tradename: | CISATRACURIUM BESYLATE |
Applicant: | Accord Hlthcare |
Ingredient: | cisatracurium besylate |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 2MG BASE/ML | ||||
Approval Date: | Jun 16, 2017 | TE: | RLD: | No |
Complete Access Available with Subscription